Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7104514

CCOC(=O)c1cn(Cc2cccc(C=NN)c2)cc1Cc1ccc(NC(C)=O)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GNRHR P30968 2/20 0.36
PPID Q08752 1/20 0.35
OPRK1 P41145 2/20 0.34
MAPT P10636 3/20 0.34
TP53 P04637 1/20 0.34
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
CHRM2 P08172 1/20 0.32
CHRM3 P20309 1/20 0.32
EPHX2 P34913 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
PDE3B Q13370 2/20 0.32
PDE3A Q14432 2/20 0.32
NAMPT P43490 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7104507 1.00 LMNA (0.36) LMNASMN1; SMN2GNRHRPPIDOPRK1
Trifluoroacetic Acid SCHEMBL6161851 0.91 PDE3B (0.38) SMN1; SMN2MAPTTP53MEN1KMT2A
Trifluoroacetic Acid SCHEMBL6161844 0.91 PDE3B (0.38) SMN1; SMN2MAPTTP53MEN1KMT2A
Trifluoroacetic Acid SCHEMBL6173089 0.90 MAPT (0.39) LMNASMN1; SMN2MAPTTP53MEN1
Trifluoroacetic Acid SCHEMBL6173094 0.90 MAPT (0.39) LMNASMN1; SMN2MAPTTP53MEN1
Trifluoroacetic Acid SCHEMBL6167880 0.89 SMN1; SMN2 (0.34) SMN1; SMN2MAPTMEN1KMT2APDE3B
Trifluoroacetic Acid SCHEMBL6167885 0.89 SMN1; SMN2 (0.34) SMN1; SMN2MAPTMEN1KMT2APDE3B
Trifluoroacetic Acid SCHEMBL6165985 0.89 KLKB1 (0.33) SMN1; SMN2OPRK1MAPTEPHX2KMT2A
Trifluoroacetic Acid SCHEMBL6165992 0.89 KLKB1 (0.33) SMN1; SMN2OPRK1MAPTEPHX2KMT2A
Trifluoroacetic Acid SCHEMBL7106592 0.88 GRM2 (0.34) LMNASMN1; SMN2MAPTKMT2APDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof LG CHEM INVESTMENT LTD. (KR) 2003-04-03 US claimed
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof LG CHEM INVESTMENT LTD. (KR) 2003-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065176-A1 Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof F2, F12, TFPI LMNA 772/4885SMN1; SMN2 3889/4885GNRHR 2130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.